Magnetic Resonance-Guided Radiotherapy for Unresectable Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Case Series and Review of Treatment Options
Current Oncology · 16.07.2026 · 33 (7) · 425
DOI: 10.3390/curroncol33070425 ↗Kurz gefasst
Fallbericht in der Zeitschrift Current Oncology, online erschienen am 16.07.2026. Verfasst von Nam Kyu Kang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Magnetic Resonance Imaging, Radiotherapy, Image-Guided. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bile duct tumor thrombus (BDTT) is a rare manifestation of hepatocellular carcinoma (HCC) that causes obstructive jaundice and is associated with a poor prognosis, although a treatment algorithm has yet to be established. We review the treatment landscape for HCC with BDTT, including surgical, transarterial, systemic, and radiotherapy options, and report, to our knowledge, the first case series of magnetic resonance-guided radiotherapy (MRgRT) for this condition. Four patients with unresectable HCC and BDTT were treated on a 0.35-T MR-linac with real-time cine-MRI gating (50 Gy in 5 fractions, n = 3; 40 Gy in 5 fractions, n = 1), with tumor response assessed by modified RECIST. All patients completed treatment without interruption. The best response was complete response in two patients and partial response in two, and obstructive jaundice resolved in both affected patients. The maximum radiation-attributed toxicity was a transient grade 3 bilirubin elevation that resolved without biliary intervention, and no treatment-related deaths occurred. Overall survival ranged from 5.5 to 29 months, with the two Child-Pugh class A patients without portal vein tumor thrombosis surviving 22 and 29 months. MRgRT for HCC with BDTT appears feasible with acceptable short-term safety and merits prospective evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
ORCID-Profile: Jung Hyun Kwon, Soon Kyu Lee, Myungsoo Kim
Zitieren
APA
Kang, N. K., Lee, S. J., Kang, H. J., Shin, H. J., Kwon, J. H., Lee, S. K., & Kim, M. (2026). Magnetic Resonance-Guided Radiotherapy for Unresectable Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Case Series and Review of Treatment Options. Current Oncology, 33(7), 425. https://doi.org/10.3390/curroncol33070425
Vancouver
Kang NK, Lee SJ, Kang HJ, Shin HJ, Kwon JH, Lee SK, et al. Magnetic Resonance-Guided Radiotherapy for Unresectable Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Case Series and Review of Treatment Options. Current Oncology. 2026;33(7):425. doi:10.3390/curroncol33070425
BibTeX
@article{Kang2026,
author = {Kang, Nam Kyu and Lee, So Jung and Kang, Hye Jin and Shin, Hun-Joo and Kwon, Jung Hyun and Lee, Soon Kyu and Kim, Myungsoo},
title = {Magnetic Resonance-Guided Radiotherapy for Unresectable Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Case Series and Review of Treatment Options},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {7},
pages = {425},
doi = {10.3390/curroncol33070425}
}
EUVIMED